4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001567619-22-002399
Options or other derivatives
- Chief Business Officer acquired 112,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hull Hans · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-26 | Grant or award : show line 1 in the form Stock Option (right to buy) | +112,500 | 112,500 | D |
Loading xslF345X03/doc1.xml…